Kolon TissueGene, Inc. (KOSDAQ:950160)

Market Cap	3.93T
Revenue	n/a
Net Income	n/a
Shares Out	81.52M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	453,967
Average Volume	763,884
Open	48,950
Previous Close	48,900
Day's Range	46,900 - 49,950
52-Week Range	10,350 - 59,300
Beta	-0.61
RSI	55.48
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160